Acker Warren W, Plasek Joseph M, Blumenthal Kimberly G, Lai Kenneth H, Topaz Maxim, Seger Diane L, Goss Foster R, Slight Sarah P, Bates David W, Zhou Li
Division of General Medicine and Primary Care, Brigham and Women's Hospital, Boston, Mass; Geisinger Commonwealth School of Medicine, Scranton, Pa.
Division of General Medicine and Primary Care, Brigham and Women's Hospital, Boston, Mass; Department of Biomedical Informatics, University of Utah School of Medicine, Salt Lake City, Utah.
J Allergy Clin Immunol. 2017 Dec;140(6):1587-1591.e1. doi: 10.1016/j.jaci.2017.04.006. Epub 2017 May 31.
Food allergy prevalence is reported to be increasing, but epidemiological data using patients' electronic health records (EHRs) remain sparse.
We sought to determine the prevalence of food allergy and intolerance documented in the EHR allergy module.
Using allergy data from a large health care organization's EHR between 2000 and 2013, we determined the prevalence of food allergy and intolerance by sex, racial/ethnic group, and allergen group. We examined the prevalence of reactions that were potentially IgE-mediated and anaphylactic. Data were validated using radioallergosorbent test and ImmunoCAP results, when available, for patients with reported peanut allergy.
Among 2.7 million patients, we identified 97,482 patients (3.6%) with 1 or more food allergies or intolerances (mean, 1.4 ± 0.1). The prevalence of food allergy and intolerance was higher in females (4.2% vs 2.9%; P < .001) and Asians (4.3% vs 3.6%; P < .001). The most common food allergen groups were shellfish (0.9%), fruit or vegetable (0.7%), dairy (0.5%), and peanut (0.5%). Of the 103,659 identified reactions to foods, 48.1% were potentially IgE-mediated (affecting 50.8% of food allergy or intolerance patients) and 15.9% were anaphylactic. About 20% of patients with reported peanut allergy had a radioallergosorbent test/ImmunoCAP performed, of which 57.3% had an IgE level of grade 3 or higher.
Our findings are consistent with previously validated methods for studying food allergy, suggesting that the EHR's allergy module has the potential to be used for clinical and epidemiological research. The spectrum of severity observed with food allergy highlights the critical need for more allergy evaluations.
据报道食物过敏的患病率正在上升,但利用患者电子健康记录(EHR)的流行病学数据仍然稀少。
我们试图确定EHR过敏模块中记录的食物过敏和不耐受的患病率。
利用2000年至2013年间一家大型医疗保健机构EHR中的过敏数据,我们按性别、种族/族裔群体和过敏原类别确定了食物过敏和不耐受的患病率。我们检查了可能由IgE介导的反应和过敏反应的患病率。对于报告有花生过敏的患者,如有可用数据,使用放射变应原吸附试验和免疫捕获结果对数据进行验证。
在270万名患者中,我们确定了97482名(3.6%)患有1种或更多食物过敏或不耐受的患者(平均为1.4±0.1)。女性(4.2%对2.9%;P<0.001)和亚洲人(4.3%对3.6%;P<0.001)的食物过敏和不耐受患病率更高。最常见的食物过敏原类别是贝类(0.9%)、水果或蔬菜(0.7%)、乳制品(0.5%)和花生(0.5%)。在103659例确定的食物反应中,48.1%可能由IgE介导(影响50.8%的食物过敏或不耐受患者),15.9%为过敏反应。报告有花生过敏的患者中约20%进行了放射变应原吸附试验/免疫捕获检测,其中57.3%的患者IgE水平为3级或更高。
我们的研究结果与先前验证的食物过敏研究方法一致,表明EHR的过敏模块有潜力用于临床和流行病学研究。食物过敏所观察到的严重程度范围突出了对更多过敏评估的迫切需求。